Duration of Response and Progression-Free Survival with Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients with Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind. (2020). SKIN The Journal of Cutaneous Medicine, 4(5), s68. https://doi.org/10.25251/skin.4.supp.67